A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain

2006136 citationsJournal Article

Authors

Stabilized doses of oxymorphone ER were generally safe and effective over a 12-week double-blind treatment period in opioid-naive patients with CLBP.

Good health and well-being

Published in: Current Medical Research and Opinion

Volume 23, Issue 1, pp. 117-128

Field-Weighted Citation Impact: 5.57